• 'Impressive' Results for Novel Antidepressant, So Why the FDA Delay?

    2 days ago - By Medscape

    AXS-05, a combination of dextromethorphan and bupropion, appears to have a rapid and durable effect in major depression, yet its new drug application remains in FDA limbo.
    Medscape Medical News
    Read more ...